PlainRecalls
FDA Drug Moderate Class II Terminated

Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53

Reported: May 1, 2024 Initiated: March 26, 2024 #D-0471-2024

Product Description

Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53

Reason for Recall

Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.

Details

Recalling Firm
Cipla USA, Inc.
Units Affected
59244/3ml FFS packs
Distribution
USA nationwide.
Location
Warren, NJ

Frequently Asked Questions

What product was recalled?
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53. Recalled by Cipla USA, Inc.. Units affected: 59244/3ml FFS packs.
Why was this product recalled?
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 1, 2024. Severity: Moderate. Recall number: D-0471-2024.